« previous next »
Pages: [1]

Author Topic: Drug company merger may be bad news for MS drug Lemtrada  (Read 101 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
Drug company merger may be bad news for MS drug Lemtrada
« on: November 13, 2015, 06:21:12 am »
Sanofi and Genzyme, two pharmaceutical giants, merged recently and as a result the MS drug Lemtrada may have lost out to Aubagio.

This is according to a report in the New York Times business section (November 13), through a complicated series of maneuvers, Lemtrada may have been "slow walked" through the drug approval process in order to give preferential treatment to another MS drug, Aubagio.
« Last Edit: November 13, 2015, 06:24:57 am by agate »
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »